IAMA-6

N/A

Report date: 2025/06/05 16:57:30
NME

Base Information

Drug NameIAMA-6
Drug Alias NameIAMA-6ARN-23746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 12 member 2 blockers
TargetsSolute carrier family 12 member 2
Therapy Area/IndicationsAutistic DisorderNeurodevelopmental DisordersDown Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIama Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIstituto Italiano Di TecnologiaIama Therapeutics SrlIama Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutistic DisorderNeurodevelopmental DisordersDown Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A